Literature DB >> 22341521

Effects of duodenal-jejunal exclusion on beta cell function and hormonal regulation in Goto-Kakizaki rats.

Daniel de Luis1, Maria Domingo, Alejandro Romero, Manuel Gonzalez Sagrado, David Pacheco, David Primo, Rosa Conde.   

Abstract

BACKGROUND: The aim of our work was to investigate the hormones that control glycemic status and in vitro β-cell function in diabetes mellitus after a duodenal-jejunal exclusion in Goto-Kakizaki rats (Taconic, Denmark).
METHODS: Twenty-three rats (age, 12-14 wk) were randomized as follows: group 1 (n = 14), no intervention (control); or group 2 (n = 9), duodenal-jejunal exclusion.
RESULTS: In group 2, levels of glucagon and leptin were lower than in group 1 at 1 week and at 8 weeks. Glucagon-like peptide 1 levels had a significant increase at 8 weeks from basal value in group 2 and this value was higher than in group 1. The insulin secretion at 60 minutes in group 2 was higher than in group 1 (group 1, 12.9 ± 12.0 μg/L vs group 2, 41.9 ± 36.3 μg/L; P < .05). Messenger RNA (mRNA) expression of insulin at 2 months was higher in the rat pancreas of the experimental group than in the control group (group 1, .99 ± .48 mRNA amount vs group 2, 1.66 ± .33 mRNA amount; P < .05).
CONCLUSIONS: Gastrojejunal bypass in this model improves glucose ratios, with a significant increase of glucagon-like peptide 1 and decrease of homeostasis model assessment, glucagon, and leptin levels after surgery. This type of surgery improves mRNA insulin expression in pancreatic islets and insulin secretion as well.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341521     DOI: 10.1016/j.amjsurg.2011.07.020

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Amelioration of glycemic control by sleeve gastrectomy and gastric bypass in a lean animal model of type 2 diabetes: restoration of gut hormone profile.

Authors:  Hans Eickhoff; Teresa M Louro; Paulo N Matafome; Filipa Vasconcelos; Raquel M Seiça; Francisco Castro E Sousa
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

2.  New clues to bariatric surgery's benefits.

Authors:  David A Sarruf; Susan Bonner-Weir; Michael W Schwartz
Journal:  Nat Med       Date:  2012-06-06       Impact factor: 53.440

Review 3.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

4.  Preserve common limb in duodenal-jejunal bypass surgery benefits rats with type 2-like diabetes.

Authors:  Shi-Yun Zhang; Xue-Jun Sun; Jian-Bao Zheng; Wei Wang; Dong Liu; Nan-Zheng Chen; Sai He; Xiong-Wei Huo; Wanli Smith
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

5.  Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.

Authors:  Dong Sun; Kexin Wang; Zhibo Yan; Guangyong Zhang; Shaozhuang Liu; Fengjun Liu; Chunxiao Hu; Sanyuan Hu
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

6.  Improved glycemic control with proximal intestinal bypass and weight loss following gastrectomy in non-obese diabetic gastric cancer patients.

Authors:  Ali Guner; Minah Cho; Taeil Son; Hyoung-Il Kim; Sung Hoon Noh; Woo Jin Hyung
Journal:  Oncotarget       Date:  2017-11-01

7.  Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance.

Authors:  Zeynep Goktas; Naima Moustaid-Moussa; Chwan-Li Shen; Mallory Boylan; Huanbiao Mo; Shu Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2013-06-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.